ArticleScientific reports2025

Genetic evidence from Mendelian randomization links CD40 levels to increased risk of estrogen receptor-positive breast cancer.

Junyu Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.